Sequome engineers biological sequences to develop therapeutics, building on our sequence→function AI, Gene Genie, published on the cover of Nature.
We’re fortunate to have had the opportunity to collaborate with ~half of Top-10 Pharma (watch our panel with J&J at the BIO International Convention on YouTube) & Google DeepMind (on AI co-scientist, also published on the cover of Nature), and we haven’t even publicly launched yet!
Our investors include a former CEO of Novartis, several Harvard Medical School professors, a MacArthur Genius Fellow faculty at Stanford, alongside leading Silicon Valley AI investors.